Pura Vida Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,646
Closed -$856K 221
2022
Q3
$856K Buy
+2,646
New +$838K 0.05% 161
2021
Q3
Sell
-65,922
Closed -$15.1M 305
2021
Q2
$15.1M Buy
+65,922
New +$13.2M 0.47% 47
2017
Q2
Sell
-64,250
Closed -$5.4M 82
2017
Q1
$5.4M Buy
+64,250
New +$5.15M 1.6% 31
2016
Q4
Sell
-93,375
Closed -$7.49M 80
2016
Q3
$7.49M Buy
93,375
+37,375
+67% +$2.99M 2.28% 12
2016
Q2
$4.41M Buy
56,000
+14,000
+33% +$1.05M 1.87% 17
2016
Q1
$3.02M Buy
42,000
+7,500
+22% +$567K 1.38% 28
2015
Q4
$2.91M Sell
34,500
-9,750
-22% -$809K 1.23% 36
2015
Q3
$3.7M Buy
44,250
+17,750
+67% +$1.5M 2.11% 16
2015
Q2
$2.24M Buy
+26,500
New +$2.02M 1.15% 42

Other funds holding LLY

Pura Vida Investments's LLY Position: Q4 2022 in Review

Pura Vida Investments sold out of Eli Lilly (LLY) in Q4 2022, closing a stake of 2,646 shares — an estimated $856K sold.

Pura Vida Investments first reported a position in LLY in Q2 2015 and held it in 9 quarters. The position peaked at $15.1M in Q2 2021. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Pura Vida Investments reported no remaining Eli Lilly position as of Q4 2022 after selling out during the quarter.
  • Pura Vida Investments sold 2,646 Eli Lilly shares in Q4 2022, an estimated $856K.
  • Pura Vida Investments first reported a position in Eli Lilly in Q2 2015 and held it in 9 quarters.
  • Pura Vida Investments's Eli Lilly position peaked at $15.1M in Q2 2021.
  • 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.